NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
NBRV
Delisted
NBRV was delisted on the 31st of July, 2023.
50 hedge funds and large institutions have $14.3M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
62% less capital invested
Capital invested by funds: $37.3M → $14.3M (-$22.9M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
50
Holding in Top 10
–
Calls
$216K
Puts
$26K
Top Buyers
| 1 | +$980K | |
| 2 | +$941K | |
| 3 | +$112K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$72K |
| 5 |
Goldman Sachs
New York
|
+$69K |
Top Sellers
| 1 | -$4.58M | |
| 2 | -$604K | |
| 3 | -$491K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$384K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$271K |